Morra et al. assessed the association of protein-truncating variants and rare missense variants in nine genes (ATM, BARD1, BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D, and TP53) with the risk of CBC [153]. This evidence concerns the gene BRCA2 and complete blood cell count.